Skip to main navigation
Skip to search
Skip to main content
Help & FAQ
Home
Profiles
Organisations
Research output
Grants
Datasets
Prizes / Awards
Engagement / Activities
Press / Media
Units
Equipment
Impacts
Search by expertise, name or affiliation
A Randomised Open-Label, Phase 1b Study of the Safety of Pirfenidone Solution for Inhalation (AP01) in Patients with Idiopathic Pulmonary Fibrosis (ATLAS Study)
Lake, Fiona
(Chief Investigator)
UWA Medical School
Overview
Project Details
Status
Active
Effective start/end date
1/05/19
→
31/01/23
Funding
Avalyn Pharma:
AUD10,166.00
Avalyn Pharma:
AUD30,979.00
Avalyn Pharma
Avalyn Pharma
Avalyn Pharma:
AUD20,699.00
View all
View less